‘Treg’ startup Sonoma expands with plans for manufacturing plant

SourceBiopharma Dive
Date Published08/24/2022
Author NameNed Pagliarulo
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Sonoma Biotherapeutics
Type of work Manufacturing
Reshoring category:Reshoring
Year reshoring announced:2022
Domestically, the work will be done:In-house
Capital investment ($):335
City reshored to:Seattle
State(s) reshored to:WA
If relevant, work nearshored to:-
Product(s) reshoredt-cell therapies
Find Reshoring Articles